Spotlight on the January 15 Issue
Citation Manager Formats
Make Comment
See Comments

Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis
Clinical and MRI data at onset and clinical follow-up at 1 year were collected for 1,165 patients with clinically isolated syndromes. Involvement of specific white matter tracts traversed by fibers involved in motor function and near the corpus callosum was associated with a higher risk of clinical conversion to multiple sclerosis.
See p. 234; Editorial, p. 230
Clinically feasible MTR is sensitive to cortical demyelination in MS
This study sets the stage for detection of presently undetectable cortical demyelination, which may exceed white matter demyelination in patients with MS. Clinically feasible magnetization transfer ratio (MTR) imaging …
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis
- Clinically feasible MTR is sensitive to cortical demyelination in MS
- Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children
- New NBIA subtype: Genetic, clinical, pathologic, and radiographic features of MPAN
- The spectrum of nonmotor symptoms in early Parkinson disease
- Effect of study partner on the conduct of Alzheimer disease clinical trials
- Recovery of the T-cell repertoire in CIDP by IV immunoglobulins
- Footnotes
- Info & Disclosures